NASDAQ:SUPG - Astex Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Astex Pharmaceuticals, Inc., formerly SuperGen, Inc. is a pharmaceutical company. The Company is primarily engaged in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. The Company is developing a pipeline of medicines for partnership with pharmaceutical companies. It is also engaged in the application of fragment-based drug discovery and development of small-molecule therapeutics. Using its fragment-based drug discovery platform, Pyramid, Astex Therapeutics Limited, a wholly owned subsidiary, has built a pipeline of molecularly-targeted drugs for large pharmaceutical partners and internal development that are at various stages of clinical, pre-clinical and early discovery development. In October 2013, Otsuka Holdings Co Ltd announced that its wholly owned subsidiary, Otsuka Pharmaceutical Co., Ltd completed, through its wholly owned indirect subsidiary Autumn Acquisition Corporation, its acquisition of Astex Pharmaceuticals, Inc.

Receive SUPG News and Ratings via Email

Sign-up to receive the latest news and ratings for SUPG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:SUPG
CUSIPN/A
Phone+1-925-5600100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Astex Pharmaceuticals (NASDAQ:SUPG) Frequently Asked Questions

What is Astex Pharmaceuticals' stock symbol?

Astex Pharmaceuticals trades on the NASDAQ under the ticker symbol "SUPG."

Has Astex Pharmaceuticals been receiving favorable news coverage?

Press coverage about SUPG stock has trended positive on Wednesday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Astex Pharmaceuticals earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned news headlines about the healthcare company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the near future.

How do I buy shares of Astex Pharmaceuticals?

Shares of SUPG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Astex Pharmaceuticals' official website?

The official website for Astex Pharmaceuticals is http://astx.com/.

How can I contact Astex Pharmaceuticals?

Astex Pharmaceuticals' mailing address is Suite 200, 4140 Dublin Blvd., DUBLIN, CA 94568, United States. The healthcare company can be reached via phone at +1-925-5600100.


MarketBeat Community Rating for Astex Pharmaceuticals (NASDAQ SUPG)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  81
MarketBeat's community ratings are surveys of what our community members think about Astex Pharmaceuticals and other stocks. Vote "Outperform" if you believe SUPG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SUPG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel